| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | PACIFIC EDGE LIMITED: D&O Initial Disclosure | 1 | NZX | ||
| Do | PACIFIC EDGE LIMITED: NZX Initial D & O Disclosure for Simon Flood | 1 | ASX | ||
| Mi | PACIFIC EDGE LIMITED: Pacific Edge Names Simon Flood Chairman Designate | 1 | NZX | ||
| 26.11. | PACIFIC EDGE LIMITED: Pacific Edge Appoints Chief Commercial Officer | 1 | NZX | ||
| 24.11. | PACIFIC EDGE LIMITED: Financial Results for the Half Year to 30 September 2025 | 1 | NZX | ||
| 24.11. | PACIFIC EDGE LIMITED: HY26 Financial Result | - | ASX | ||
| 06.11. | PACIFIC EDGE LIMITED: Interim Financial Result to be Announced 25 November 2025 | 1 | NZX | ||
| PACIFIC EDGE Aktie jetzt für 0€ handeln | |||||
| 14.10. | PACIFIC EDGE LIMITED: ASX Appendix 3H | 2 | NZX | ||
| 14.10. | PACIFIC EDGE LIMITED: NZX Capital Change Notices | - | ASX | ||
| 14.10. | PACIFIC EDGE LIMITED: Capital Change Notices - Options lapsed and exercised | 2 | NZX | ||
| 14.10. | PACIFIC EDGE LIMITED: Application for quotation of securities - PEB | 2 | ASX | ||
| 14.10. | PACIFIC EDGE LIMITED: Notification of cessation of securities - PEB | - | ASX | ||
| 13.10. | PACIFIC EDGE LIMITED: Q2 26 Cxbladder Volumes Weaken After Coverage Loss | - | NZX | ||
| 14.09. | PACIFIC EDGE LIMITED: Novitas Proposes Expert Panel in Response to 2025 AUA Guide | - | NZX | ||
| 10.09. | PACIFIC EDGE LIMITED: CMS Recommends US$1,328 Price for Triage Plus | 2 | ASX | ||
| 25.08. | PACIFIC EDGE LIMITED: NZ RegCo Share Price Enquiry into Pacific Edge Limited | - | NZX | ||
| 25.08. | PACIFIC EDGE LIMITED: NZX - Capital Change Notice - issue of shares | - | ASX | ||
| 25.08. | PACIFIC EDGE LIMITED: Application for quotation of securities - PEB | - | ASX | ||
| 25.08. | PACIFIC EDGE LIMITED: ASX Appendix 2A | - | NZX | ||
| 25.08. | PACIFIC EDGE LIMITED: Capital Change Notice - issue of shares | - | NZX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,510 | +1,92 % | EQS-DD: Siemens Healthineers AG: Elisabeth Staudinger-Leibrecht, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.11.2025 / 17:23... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,040 | +0,08 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,720 | -0,60 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 35,860 | +1,21 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,790 | +1,79 % | BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions | ||
| GERRESHEIMER | 25,860 | -1,52 % | Cancom, Delivery Hero, Gerresheimer, Hugo Boss, Puma, RWE, TUI - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,550 | +0,77 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| BETA BIONICS | 29,380 | -2,07 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 43,440 | +0,32 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| PROGYNY | 24,020 | -0,54 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 158,96 | -1,85 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| NUTEX HEALTH | 160,95 | +2,65 % | Nutex Health extends share repurchase plan | ||
| RXSIGHT | 12,660 | +1,36 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 38,650 | -2,45 % | Castle Biosciences, Inc.: New Data Confirms Performance of DecisionDx-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity | FRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data... ► Artikel lesen | |
| UNITEDHEALTH | 284,15 | -0,80 % | UnitedHealth: Milliarden-Deal voraus | Der unter Druck stehende größte US-Krankenversicherer UnitedHealth trennt sich wohl von einem weiteren Geschäftsbereich. Wie die Nachrichtenagentur Reuters am Wochenende berichtet, verkauft das Unternehmen... ► Artikel lesen |